First Recreational Cannabis Dispensary Opens on Long Island
Long Island opened up its first recreational dispensary.
Recently, Long Island welcomed its first cannabis dispensary targeted for recreational use. The stores’ location is in East Farmingdale and is called “Strain Stars” (1).
It is a family-owned business and becomes the 19th cannabis dispensary to open its doors in New York. The Empire State legalized recreational cannabis in 2021 but surprisingly, only 4 towns on Long Island have accepted to permit retail stores.
New York State has given priority for licenses to individuals with a prior cannabis conviction or to their relatives.
Reference
- Long Island’s First Recreational Marijuana Dispensary Opens Up in East Farmingdale https://abc7ny.com/long-island-marijuana-dispensary-ny-dispensaries/13479278/ (accessed Jul 11, 2023).
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
